PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 24, 2026Archives of Microbiology0 citations

Lactilactobacillus curvatus TH19-7: a broad-spectrum antimicrobial probiotic targeting skin pathogens and mitigating infection-associated dermal damage in vitro

View Full Paper
TNTrang Thi Minh NguyenXJXiangji JinQZQiwen Zheng

Key Points

  • This research investigates the efficacy of Lactilactobacillus curvatus TH19-7 as a probiotic targeting skin pathogens and mitigating associated tissue damage.
  • In vitro evaluation of antimicrobial activity against skin pathogens
  • Assessment of cellular morphology and safety profile
  • Evaluation of antioxidant capacity and anti-inflammatory effects
  • L. curvatus TH19-7 showed significant antimicrobial activity against Staphylococcus aureus and Escherichia coli
  • Demonstrated low Minimum Inhibitory Concentrations (MICs) indicating high potency
  • Exhibited anti-inflammatory effects by suppressing nitric oxide production in macrophages

Abstract

Effective management of skin infections requires antimicrobial agents that can eradicate pathogens and mitigate associated tissue damage. This in vitro study evaluates the potential of Lactilactobacillus curvatus TH19-7, isolated from kimchi, as a safe and broad-spectrum antimicrobial probiotic. The selected lactic acid bacterium was identified by 16S rRNA sequencing and biochemical profiling, followed by in vitro evaluation of antimicrobial activity (MIC/MBC), cellular morphology (SEM), safety (antibiotic susceptibility, hemolysis, bile salt hydrolase activity, and D-lactic acid production), antioxidant capacity (DPPH and ABTS assays), and anti-inflammatory effects assessed by macrophage viability and NO inhibition. The strain demonstrated significant bactericidal activity, with its cell-free supernatant inhibiting the growth of key cutaneous pathogens, including Staphylococcus aureus, Staphylococcus epidermis , Cutibacterium acnes , Pseudomonas aeruginosa , Escherichia coli ( E. coli ), and Candida albicans by 64.7–83.5% at 2.5 mg/mL. Minimum Inhibitory and Bactericidal Concentrations (MIC/MBC) confirmed high potency, with low MICs of 1.25 mg/mL against several targets. Crucially, scanning electron microscopy revealed that the antimicrobial mechanism involves direct cellular lysis and severe membrane deformation in bacterial cells, particularly with E. coli, with complete cell disruption. Beyond pathogen eradication, the strain exhibited significant radical scavenging capacity (ABTS IC₅₀ = 39.1 µg/mL) and suppressed nitric oxide production in macrophages by 34.8%, indicating potential to mitigate oxidative and inflammatory tissue damage. Furthermore, L. curvatus TH19-7 displayed a strong safety profile, demonstrating a non-hemolytic (γ-hemolytic) phenotype, susceptibility to a broad range of clinically relevant antibiotics, minimal D-lactate production, and demonstrated tolerance to simulated gastrointestinal stress conditions. These findings position L. curvatus TH19-7 as a promising topical probiotic that directly eliminates pathogens through membrane disruption and concurrently aid tissue recovery through immunomodulatory and antioxidant activities.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Nguyen et al. (2026) studied this question.

synapsesocial.com/papers/699ceda059e024144310b783https://doi.org/10.1007/s00203-026-04763-3
Ask AI
Helpful
Bookmark
Share
View Full Paper